MHC class I and II-deficient humanized mice are suitable tools to test the long-term antitumor efficacy of immune checkpoint inhibitors and T-cell engagers
- Eguren-Santamaria, I.
- Fernández de Piérola, E.
- Camps, G.
- Martín-Muñoz, P.
- Campos, M.
- Cuculescu, D.
- Aguilera-Buenosvinos, I.
- Rodríguez López, I.
- Salido-Vallejo, R.
- Alexandru, R.
- De Andrea, C.E.
- Álvarez-Gigli, L.
- Berraondo, P.
- Melero, I.
- Sanmamed, M.F.
Revue:
Journal for immunotherapy of cancer
ISSN: 2051-1426
Année de publication: 2024
Volumen: 12
Número: 9
Type: Article
